ARNTL inhibits the malignant behaviors of oral cancer by regulating autophagy in an AKT / mTOR pathway‐dependent manner
Cancer Science · 2023
DOI: 10.1111/cas.15928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von KuiChi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Autophagy, Proto-Oncogene Proteins c-akt, ARNTL Transcription Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation Project of Chongqing, Science Project of the Chongqing Municipal Health Commission. The First batch of key Disciplines On Public Health in Chongqing.
Abstract (Originalsprache)
Current studies have shown that ARNTL, an important clock gene, plays an anticancer role and is downregulated in certain types of cancer. However, the biological functions and mechanisms of ARNTL in tumors remain largely unknown. This study aimed to elucidate how ARNTL‐induced autophagy impacts the biological properties of tongue squamous cell carcinoma (TSCC) cells and the mechanisms by which ARNTL expression activates autophagy. ARNTL was stably overexpressed in TSCC cells to investigate its functions in vitro and in vivo. We found that activation of autophagy induced by ARNTL decreases cell proliferation, enhances cell death, and hinders the migratory ability of TSCC cells. Moreover, ARNTL antagonizes the AKT/mTOR pathway, which potentiates autophagy induction. The manipulation of Akt activation cancels the effects of ARNTL overexpression on the biological behaviors of TSCC cells. Furthermore, after the addition of SC79, the upregulated BAX expression due to ARNTL overexpression and downregulated expressions of BCL‐2 and MMP2 were remarkably rescued. In vivo tumorigenicity assays and immunohistochemistry also confirmed that ARNTL overexpression suppresses tumor development. Our study found for the first time that ARNTL inhibits the malignant behaviors of oral cancer cells by regulating autophagy in an AKT/mTOR pathway‐dependent manner, which provides a novel theoretical basis for the potential future application of ARNTL to treat patients with oral cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China.
- Stomatological Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: HanXue Li
Förderung
- Natural Science Foundation Project of Chongqing
- Science Project of the Chongqing Municipal Health Commission. The First batch of key Disciplines On Public Health in Chongqing
Zitieren
APA
Chen, K., Li, H., Li, Y., Yang, Z., Luo, J., & Zhou, Z. (2023). ARNTL inhibits the malignant behaviors of oral cancer by regulating autophagy in an AKT / mTOR pathway‐dependent manner. Cancer Science. https://doi.org/10.1111/cas.15928
Vancouver
Chen K, Li H, Li Y, Yang Z, Luo J, Zhou Z. ARNTL inhibits the malignant behaviors of oral cancer by regulating autophagy in an AKT / mTOR pathway‐dependent manner. Cancer Science. 2023. doi:10.1111/cas.15928
BibTeX
@article{Chen2023,
author = {Chen, KuiChi and Li, HanXue and Li, YueHeng and Yang, ZhengYan and Luo, Jun and Zhou, Zhi},
title = {ARNTL inhibits the malignant behaviors of oral cancer by regulating autophagy in an AKT / mTOR pathway‐dependent manner},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15928}
}
EUVIMED